We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+33.48%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$611M
AUM Growth
+$11.7M
(+2%)
Cap. Flow
-$91.9M
Cap. Flow
% of AUM
-15.04%
Top 10 Holdings %
Top 10 Hldgs %
4.77%
Holding
1,794
New
573
Increased
263
Reduced
313
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Best Buy
BBY
|
+$2.79M |
| 2 |
Bath & Body Works
BBWI
|
+$2.78M |
| 3 |
Advanced Micro Devices
AMD
|
+$2.7M |
| 4 |
NVIDIA
NVDA
|
+$2.4M |
| 5 |
ExxonMobil
XOM
|
+$2.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$10.9M |
| 2 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$7.99M |
| 3 |
ORPH
Orphazyme A/S
ORPH
|
+$5.06M |
| 4 |
BridgeBio Pharma
BBIO
|
+$3.35M |
| 5 |
BPY
Brookfield Property Partners L.P. Limited Partnership Units
BPY
|
+$3.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.42% |
| 2 | Technology | 16.03% |
| 3 | Healthcare | 14.17% |
| 4 | Industrials | 13.91% |
| 5 | Financials | 11.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DOC
626
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $372K | 0.06% |
+20,886
| New | +$374K |
|
627
Green Dot
GDOT
$745M
| $371K | 0.06% |
+6,652
| New | +$378K |
|
628
Madrigal Pharmaceuticals
MDGL
$11.8B
| $371K | 0.06% |
+3,334
| New | +$408K |
|
629
Energous
WATT
$102M
| $369K | 0.06% |
+341
| New | +$450K |
|
630
Rocket Pharmaceuticals
RCKT
$394M
| $367K | 0.06% |
6,699
-13,767
| -67% | -$502K |
|
631
DigitalBridge
DBRG
$2.95B
| $366K | 0.06% |
+19,000
| New | +$304K |
|
632
NorthWestern Energy
NWE
$4.43B
| $366K | 0.06% |
6,273
-10,674
| -63% | -$593K |
|
|
CIO
633
DELISTED
City Office REIT
CIO
| $364K | 0.06% |
37,227
-5,310
| -12% | -$43.7K |
|
634
Aon
AON
$76B
| $363K | 0.06% |
+1,717
| New | +$351K |
|
|
CEQP
635
DELISTED
Crestwood Equity Partners LP
CEQP
| $362K | 0.06% |
+19,051
| New | +$312K |
|
636
Mercury Systems
MRCY
$6.52B
| $361K | 0.06% |
+4,104
| New | +$312K |
|
637
Akebia Therapeutics
AKBA
$252M
| $360K | 0.06% |
128,626
+38,963
| +43% | +$114K |
|
|
RDHL
638
Redhill Biopharma
RDHL
$3.68M
| $360K | 0.06% |
+45
| New | +$404K |
|
|
CDTX
639
DELISTED
Cidara Therapeutics
CDTX
| $359K | 0.06% |
8,976
+7,684
| +595% | +$382K |
|
640
York Water
YORW
$514M
| $359K | 0.06% |
7,708
+1,129
| +17% | +$51.7K |
|
|
GNMK
641
DELISTED
GenMark Diagnostics, Inc
GNMK
| $359K | 0.06% |
+24,578
| New | +$326K |
|
642
3M
MMM
$94.3B
| $358K | 0.06% |
2,448
-476
| -16% | -$67.6K |
|
643
Blink Charging
BLNK
$87.9M
| $357K | 0.06% |
+8,358
| New | +$165K |
|
644
Southwest Airlines
LUV
$23B
| $357K | 0.06% |
+7,649
| New | +$331K |
|
645
PNC Financial Services
PNC
$101B
| $356K | 0.06% |
+2,389
| New | +$305K |
|
|
MTEM
646
DELISTED
Molecular Templates, Inc.
MTEM
| $356K | 0.06% |
2,529
+1,756
| +227% | +$259K |
|
|
APLS
647
DELISTED
Apellis Pharmaceuticals
APLS
| $355K | 0.06% |
6,215
-9,266
| -60% | -$392K |
|
648
Dropbox
DBX
$8.12B
| $355K | 0.06% |
16,009
+144
| +0.9% | +$2.93K |
|
649
Vanguard Information Technology ETF
VGT
$149B
| $355K | 0.06% |
+8,024
| New | +$330K |
|
650
Commault Systems
CVLT
$5.61B
| $354K | 0.06% |
6,396
+1,229
| +24% | +$57.4K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q4 2020 Portfolio in Review
As of Q4 2020, GSA Capital Partners held 1,794 positions worth $611M, up 2% from $600M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.
GSA Capital Partners withdrew a net $91.9M in Q4 2020, closing 643 positions and reducing 313 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $10.9M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
Against the trend, GSA Capital Partners opened a new position in Best Buy worth $2.49M.
- GSA Capital Partners's largest Q4 2020 buy was Best Buy: 24,945 shares worth $2.49M.
- GSA Capital Partners added most to Advanced Micro Devices in Q4 2020, an estimated $2.7M increase.
- GSA Capital Partners's biggest Q4 2020 reduction was BridgeBio Pharma, cutting an estimated $3.35M.
- GSA Capital Partners fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2020, selling an estimated $10.9M.
- GSA Capital Partners's ten largest holdings make up 4.8% of its $611M portfolio in Q4 2020.
- GSA Capital Partners opened 573 new positions and closed 643 in Q4 2020.
- GSA Capital Partners's portfolio value rose 2% quarter-over-quarter to $611M.
Based on GSA Capital Partners's 13F filing for Q4 2020, filed 3 Feb 2021.